Gaming
Entertainment
Music
Sports
Business
Technology
News
Design
Fitness
Science
Histoy
Travel
Animals
DIY
Fun
Style
Photography
Lifestyle
Food
2018-07-19T09:55:07.822Z
0
{"feed":"WSJcom-Markets","feedTitle":"WSJ.com: Markets","feedLink":"/feed/WSJcom-Markets","catTitle":"Business","catLink":"/cat/bussiness"}
Biotech stocks are hot tickets once again on Wall Street and that is bringing a wave of initial public offerings. The risk is the high demand for these companies is offset by a wave of new supply.
Tech giants like Amazon, Apple and Google are delivering above-average growth, but the cost of staying competitive is rising more.
Streaming company’s market value got too rich even despite strong growth.
Using the reserve to curb summer pump prices at a time the economy is booming and midterm elections loom would be a strategic blunder, leaving the country exposed in the event of an actual oil shortage.
Retail sales are strong, but shoppers are borrowing more to fund their purchases. That may make sense, or leave people struggling to pay off debt.
For fans of high political drama, recent months have been packed with excitement. For markets, not so much. In the battle between economics and politics, faith in growth still has the upper hand for now.
A sharp slowdown in investment and contracting shadow-banking credit are reliable signs of difficulties ahead for China.
Netflix has had an astonishing year. Its shares surpassed $400, up 110% since January, and it was nominated for 112 Emmy Awards, more than any other television network, including HBO, which had held that distinction for 17 years.
German company could become the first foreign car maker to majority own its operations in China.
Fear of being left behind is a powerful force among fund managers, even if it means taking big risks.
Investment in China is faltering just as trade tensions heat up. But the situation is actually even worse than it appears—a sign the long-awaited hit from China’s debt crackdown has arrived.
Pfizer’s decision to defer drug price increases could ripple through the drug supply chain, which benefits when drug prices go up.
It’s official: Disney’s $71 billion offer for 21st Century Fox is actually worth more than $90 billion. Both sides of the Atlantic are now watching Comcast.
After a brief May hiatus, a full-fledged Sino-U.S. trade fight looks increasingly likely. The deciding factor might not be what you think.
PepsiCo shares had their biggest percentage increase in nearly a decade Tuesday morning on hopes that the company is arresting the decline of its core, domestic beverages business. Investors are celebrating prematurely.
It has been all downhill for international bank stocks this year. One reason why this trend will likely continue is the strengthening dollar.
The higher the price goes in the bidding for 21st Century Fox’s assets, the less room there is for error in managing and extracting value from the assets.
China’s crackdown on shadow banking has caused some high-profile blowups. Now it’s driving the country’s car makers off course.
Crackdown on fake accounts raises doubts about the company’s recent growth.
Earnings growth probably wasn’t as torrid in the second quarter as in the first, but was still plenty strong.